Non-Hodgkin Lymphoma Flashcards
The earliest IHC marker for B-lineage differentiation.
CD19
Acquired late in pre-B-cell stage of maturation; lost at the plasma cell stage.
CD20
Strongly positive: half of lymphoblastic lymphoma/leukemia; all mature B-cell lymphomas; Reedsternberg cells in 1/4 cases of HL
CD20: cytoplasmic staining
IHC marker found in follicular dendritic cells and some B lymphocytes; helps identify the hyperplastic islands of dendritic cells in angioimmunoblastic T-cell lymphoma.
CD21
IHC marker strongly expressed in hairy cell leukemia.
CD22
IHC marker that is most useful in distinguishing B-cell CLL/SLL from other entities and remains present in CLL/SLL that has undergone large cell transformation.
CD23
Expressed in nearly all of the assayed precursor B-cell lymphoblastic lymphoma/leukemias, with no T-cell staining. Also positive in mature B-cell lymphomas.
CD79a
Strongly stains the cytoplasm of most hairy cell leukemias, marginal zone lymphomas, and large cell lymphomas
DBA.44
Normal lymph node: CD79a positive as marker for early B-cell antigen
Mantle zone
Most germinal centers
Scattered interfollicular zone
Normal lymph node: CD2 positive areas as marker for early T-cell antigen.
Most interfollicular lymphocytes as well as scattered in light zone of germinal center
IHC marker for early T-cell antigen in a normal lymph node.
CD2
Positive with most T-cell lymphomas except anaplastic large cell lymphomas and NK leukemias/lymphomas. Very specific for T-cell derivation.
CD3 (cell membrane)
It interacts with HLA class II during antigen recognition, and defines a helper-inducer subset of T cells. Expressed in most mature T-cell lymphomas.
CD4
Detectable on the surface of most thymocytes and immature peripheral T cells and in a small subset of circulating B cells. Primarily used in the detection of B cell CLL/SLL and mantle cell lymphoma.
CD5
It has the distinction of being the most frequently lost T-subset marker in malignancies, particularly on mycosis fungiodes.
CD7
Also present on non-T-cell malignancies, including NK tumors and AML
CD7
This antigen defines the suppressor/cytotoxic T-cell subset.
CD8
t(2;5)
Anaplastic large cell lymphoma
Expression is limited to ALCL and rare DLBCL
ALK (anaplastic lymphoma kinase): cytoplasm and nucleus
Also CD30+, EMA+, CD15-
t(11;14)
Mantle cell lymphoma
Hallmark of mantle cell lymphomas. Weaker signal in hairy cell leukemia and plasmacytoma.
Cyclin D1 (aka BCL-1 and PRAD 1): nuclear
t(14;18)
Follicular lymphoma
Found in app 3/4 of cases of follicular lymphoma.
BCL-2: stains malignant follicles
Reversed pattern in lymph nodes exhibiting follicular hyperplasia
Normally present in the cytoplasm of follicular mantle B lymphocytes, occasional germinal center cells, and many T lymphocytes.
BCL-2
Expressed normally in germinal center lymphocytes.
BCL-6
Expressed in a variety of B-cell neoplasms. Also detected in L&H variants of nodular lymphocyte predominant Hodgkin disease.
BCL-6
Ag associated with beta 2 macroglobulin. Found in a subset of precursor T-lymphoblastic lymphoma/leukemia.
CD1a
Almost always present on the surface of precursor B lymphoblastic and Burkitt’s lymphomas, many FL and some DLBCL along with MM
CD10 (CALLA)
X hapten or Lewis X antigen
CD15
Marker for RS cells of classical HL. Also used to stain adenocarcinomas.
CD15: membranous with a paranuclear dot-like Golgi localization
IL-2 receptor. Expressed on hairy cell leukemia and adult T-cell leukemia/lymphoma.
CD25
Ki-67 index (nuclear staining)
Burkitt’s lymphoma
BCL-2 positivity in enlarged follicles
Follicular lymphoma
BCL-2 positivity around follicles
Reactive hyperplasia
Almost always present in the nucleus of lymphoblastic lymphoma cells
TdT
CD20+
BCL-2+
Mantle cell lymphoma
Follicular lymphoma
Some marginal zone lymphoma
B-CLL/SLL vs Mantle cell lymphoma
B-CLL/SLL:
CD23 (+)
Cyclin D1 (-)
Mantle cell lymphoma:
CD23 (-)
Cyclin D1 (+)
B-CLL/SLL vs Follicular lymphoma
B-CLL/SLL:
CD10 (-)
CD5/CD43 (+)
Predicts poor outcome in B-CLL
ZAP-70
Mature B lymphocytes vs plasma cells
Mature B lymphocytes:
CD45RB (+)
CD20 (+)
Sensitive for follicular lymphoma but not specific
BCL-2
CD30 expressivity in a Golgi and cell membrane pattern
ALCL